Clinical Follow-Up for Duchenne Muscular Dystrophy Newborn Screening: A Proposal-Reference-Cited by-同舟云学术

Clinical Follow-Up for Duchenne Muscular Dystrophy Newborn Screening: A Proposal

Published:2016-06-13 Issue:2 Volume:54 Page:186-191
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Kwon Jennifer M.¹,Abdel-Hamid Hoda Z.²,Al-Zaidy Samiah A.³,Mendell Jerry R.⁴,Kennedy Annie⁵,Kinnett Kathi⁶,Cwik Valerie A.⁷,Street Natalie⁸,Bolen Julie⁸,Day John W.⁹,Connolly Anne M.¹⁰

Affiliation:

1. Departments of Neurology and Pediatrics; University of Rochester Medical Center; Rochester New York

2. Department of Pediatrics; University of Pittsburgh; Pittsburgh Pennsylvania

3. Department of Pediatrics; Nationwide Children's Hospital; Columbus Ohio

4. Department of Pediatrics, The Ohio State University and Center for Gene Therapy; Nationwide Children's Hospital; Columbus Ohio

5. Parent Project Muscular Dystrophy, Headquarters; Hackensack New Jersey

6. Parent Project Muscular Dystrophy; Middletown Ohio

7. Muscular Dystrophy Association; Tucson Arizona

8. National Center on Birth Defects and Developmental Disabilities; Centers for Disease Control and Prevention; Atlanta Georgia

9. Department of Neurology; Stanford University; Stanford California

10. Departments of Neurology and Pediatrics; Washington University School of Medicine in St. Louis; St. Louis Missouri

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Clinical Neurology,Physiology

Reference33 articles.

1. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy;Mah;Neuromuscul Disord,2014

2. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy;Mendell;N Engl J Med,1989

3. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the quality standards subcommittee of the American Academy of Neurology and the practice committee of the Child Neurology Society;Moxley;Neurology,2005

4. Glucocorticoid corticosteroids for Duchenne muscular dystrophy;Manzur;Cochrane Database Syst Rev,2008

5. All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy;Schram;J Am Coll Cardiol,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Early Care (0–3 Years) In Duchenne Muscular Dystrophy Meeting Report;Journal of Neuromuscular Diseases;2024-01-04

2. Safety, tolerability and pharmacokinetics of eteplirsen in young boys aged 6–48 months with Duchenne muscular dystrophy amenable to exon 51 skipping;Neuromuscular Disorders;2023-06

3. Muscular dystrophy;Neurobiology of Brain Disorders;2023

4. A pilot study of newborn screening for Duchenne muscular dystrophy in Guangzhou;Heliyon;2022-10

5. Duchenne expert physician perspectives on Duchenne newborn screening and early Duchenne care;American Journal of Medical Genetics Part C: Seminars in Medical Genetics;2022-06